[Dermatomyositis associated with glycogen storage disease type Ⅱ: a case report].

Authors:
H Zhao
H Zhao
Northwestern University Feinberg School of Medicine
United States
R Wei
R Wei
University of Colorado

Zhonghua Nei Ke Za Zhi 2017 Jun;56(6):438-440

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0578-1426.2017.06.010DOI Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
June 2017
6 Reads

Publication Analysis

Top Keywords

disease type
4
type Ⅱ
4
Ⅱ case
4
case report]
4
glycogen storage
4
storage disease
4
associated glycogen
4
[dermatomyositis associated
4
case
1
report]
1
glycogen
1
1
[dermatomyositis
1
type
1
storage
1
disease
1

Similar Publications

Phylogenetic diversity of Bradyrhizobium strains nodulating Calicotome spinosa in the Northeast of Algeria.

Syst Appl Microbiol 2018 Sep 31;41(5):452-459. Epub 2018 May 31.

IRD, Univ. Montpellier, CIRAD, INRA, SupAgro, LSTM, Montpellier, France. Electronic address:

Fifty-two slow-growing strains were isolated from root nodules of Calicotome spinosa grown in the Northeast of Algeria and grouped in 24 rep-PCR clusters. One representative strain for each profile was further phylogenetically characterized. The nearly complete 16S rRNA gene sequence indicated that all strains were affiliated to Bradyrhizobium. Read More

View Article
September 2018
14 Reads
3.28 Impact Factor

Streptococcus pneumoniae proteomics: determinants of pathogenesis and vaccine development.

Expert Rev Proteomics 2015 2;12(6):607-21. Epub 2015 Nov 2.

a Division of Applied Medicine , University of Aberdeen , Aberdeen , Scotland.

Streptococcus pneumoniae is a major pathogen that is responsible for a variety of invasive diseases. The bacteria gain entry initially by establishing a carriage state in the nasopharynx from where they migrate to other sites in the body. The worldwide distribution of the bacteria and the severity of the diseases have led to a significant level of interest in the development of vaccines against the bacteria. Read More

View Article
January 2017
6 Reads
4 PubMed Central Citations(source)
2.90 Impact Factor

CGMD: An integrated database of cancer genes and markers.

Sci Rep 2015 Jul 10;5:12035. Epub 2015 Jul 10.

Division of Animal Biotechnology, Department of Zoology, Sri Venkateswara University, Tirupati-517502, Andhra Pradesh, India.

Integrating cancer genes and markers with experimental evidence might provide valuable information for the further investigation of crosstalk between tumor genes and markers in cancer biology. To achieve this objective, we developed a database known as the Cancer Gene Marker Database (CGMD), which integrates data on tumor genes and markers based on experimental evidence. The major goal of CGMD is to provide the following: 1) current systematic treatment approaches and recent advances in different cancer treatments; 2) the aggregation of different genes and markers by their molecular characteristics and pathway associations; and 3) free access to the data compiled by CGMD at http://cgmd. Read More

View Article
July 2015
11 Reads
1 PubMed Central Citation(source)
5.08 Impact Factor

Evaluation of acute toxicity and intestinal transit time of Roxb. leaves.

Ayu 2015 Oct-Dec;36(4):437-439

Department of Agada Tantra, Mahatma Jyotiba Fule Medical College of Ayurveda, Chomu, Rajasthan, India.

Introduction: Roxb. is a shrub or small tree found throughout tropical India. Fruits and leaves of this plant are used for medicinal and food purpose. Read More

View Article
November 2016
4 Reads

Population-based service mammography screening: the Icelandic experience.

Breast Cancer (Dove Med Press) 2013 9;5:17-25. Epub 2013 May 9.

The Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.

Objective: This study analyzes the efficacy of the Icelandic population-based service mammography screening.

Material And Methods: Women aged 40-69 were invited for screening at 2-year intervals starting in November 1987. The study evaluates: (A) attendance and other screened performance parameters during 1998-2010; (B) trends in age-standardized and age-specific incidence rates during 1969-2010 and mortality rates during 1969-2010; and (C) distribution of risk factors and disease specific death rates according to mode of detection. Read More

View Article
March 2014
5 Reads
3 PubMed Central Citations(source)